Medication info
Dapagliflozin 10 mg (Dapagliflozin Propanediol Hydrate)

Dapagliflozin 10 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
White Life Sciences Co., Ltd.
Appearance
Yellow, rounded diamond-shaped film-coated tablet
Packaging
28 tablets (14 tablets/PTP×2)
Approval status
Active

MFDS item code 202201013 · Approved 2022.03.11 · Insurance code 625202280

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients undergoing dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
White Life Sciences Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

  • Type 2 diabetes
  • abnormal blood sugar control
  • cardiovascular diseases
  • cardiovascular risk factors
View approved original text

This medication is used in conjunction with dietary and exercise therapy to assist patients with type 2 diabetes in controlling their blood sugar levels. It can be used alone or in combination with other drugs. It is particularly used for patients whose blood sugar is not well controlled, especially those at risk for or with existing cardiovascular diseases. This drug helps to improve blood sugar management and reduce the risk of complications from diabetes. Therefore, it is effectively used in the treatment of type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients undergoing dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be administered to certain patients. For example, it should not be used in patients with allergies to the active ingredient or excipients, type 1 diabetes patients, patients with diabetic ketoacidosis, individuals with genetic lactose intolerance issues, and patients on dialysis. Use this drug cautiously in patients with reduced fluid volume or impaired kidney function. This medication may lower blood pressure or cause temporary changes in kidney function; therefore, it is essential to assess fluid status and kidney function thoroughly before administration and to monitor for symptoms of hypotension or changes in kidney function after administration. This drug may cause various side effects, including genital infections, urinary tract infections, hypoglycemia, reduction in fluid volume, and diabetic ketoacidosis. Genital infections are particularly common in women, especially in those with a history of past infections, who may have a higher risk of recurrence. Pregnant or breastfeeding women are advised not to use this medication, and if pregnancy is confirmed, it should be discontinued immediately. This drug may interact with other medications, particularly diuretics or hypoglycemic agents such as insulin and sulfonylureas, requiring dose adjustments to reduce the risk of hypoglycemia. Elderly patients or those with decreased kidney function are at higher risk for fluid volume reduction and hypotension, necessitating more careful use. During treatment with this medication, keep track of fluid status and monitor blood sugar levels consistently, and consult healthcare professionals immediately if any unusual symptoms arise. Furthermore, this medication does not significantly affect driving or machinery operation but caution should be taken for hypoglycemia symptoms when used with insulin or similar medications. Lastly, the safety and efficacy of this drug have not been established in children, so it is not recommended for pediatric use.

Side effects

Vulvovaginitis, balanitis and associated genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, decreased renal creatinine clearance at the start of treatment, dyslipidemia, increased serum creatinine at the beginning of treatment, elevated blood urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, gastroesophageal reflux disease, epigastric pain, diverticulosis, bowel perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, paresthesia, cerebral infarction, nerve compression, weakness, pain, ligament sprain, road traffic accident, drug overdose, ankle fracture, hand fracture, pelvic fracture, meniscus injury, thoracic vertebra fracture, tibial fracture, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulosis, bowel obstruction with air, frequent bowel movements, gastroenteritis, colonic polyp, epigastric discomfort, functional dyspepsia, erosive gastritis, gingival disorders, gingival pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, herpes zoster, sinusitis, tonsillitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like syndrome, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, heavy menstrual bleeding, genital swelling, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularity, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, hyperhidrosis eczema, dyshidrotic eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteoporosis, muscle weakness, contusion, orbital fracture, foot fracture, gastrointestinal foreign body, laceration, ligament tear, limb injury, skin abrasion, tendon rupture, dry eye, eye pain, retinal disorder, vision impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, double vision, eyelid swelling, keratitis, ocular hypertension, visual impairment, vitreous floaters, throat pain, allergic rhinitis, asthma, voice disturbance, nosebleed, obstructive sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, nocturia, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is best stored at room temperature between 1°C and 30°C. Maintaining proper temperature and airtight conditions ensures the effectiveness and safety of the medication over time.

Appearance and packaging

Appearance

Yellow, rounded diamond-shaped film-coated tablet

Package unit

28 tablets (14 tablets/PTP×2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.